Literature DB >> 8725388

Molecular mechanisms of estrogen carcinogenesis.

J D Yager1, J G Liehr.   

Abstract

In western society, the causes of several cancers--including breast, endometrium, ovary, liver, and prostate--have been linked to inappropriate and/or prolonged exposure to synthetic or endogenous steroidal hormones. In this review, we discuss the mechanisms of estrogen carcinogenesis with a focus on estrogen metabolism to 16 alpha-hydroxy estrone and 2- and 4-hydroxy catechol estrogens and the potential effects of these metabolites in vitro and in vivo on hamster liver and kidney and rat liver carcinogenesis models. The examples demonstrate that the parent compounds and their metabolites cause both nongenotoxic cell proliferative effects as well as direct and indirect genotoxic effects, which illustrates the complex nature of estrogen carcinogenesis. These effects, in combination with the metabolic state of the tissue and the timing of its exposure, may determine the cell type (organ) of tumor development and the severity of disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725388     DOI: 10.1146/annurev.pa.36.040196.001223

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  126 in total

1.  Induction of the estrogen effect-switching phenomenon by ethanol and its correction.

Authors:  L M Bershtein; E V Tsyrlina; T E Poroshina; N V Bychkova; N M Kalinina; V B Gamayunova; O G Kryukova; I G Kovalenko; D A Vasil'ev
Journal:  Neurosci Behav Physiol       Date:  2002 Nov-Dec

2.  Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer.

Authors:  Zhaoyu Li; Geetu Tuteja; Jonathan Schug; Klaus H Kaestner
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

3.  Dietary phytoestrogen intake is associated with reduced colorectal cancer risk.

Authors:  Michelle Cotterchio; Beatrice A Boucher; Michael Manno; Steven Gallinger; Allan Okey; Patricia Harper
Journal:  J Nutr       Date:  2006-12       Impact factor: 4.798

4.  Chemical modification modulates estrogenic activity, oxidative reactivity, and metabolic stability in 4'F-DMA, a new benzothiophene selective estrogen receptor modulator.

Authors:  Hong Liu; Judy L Bolton; Gregory R J Thatcher
Journal:  Chem Res Toxicol       Date:  2006-06       Impact factor: 3.739

5.  Therapeutic potential of riboflavin, niacin and ascorbic acid on carbohydrate metabolizing enzymes in secondary endometrial carcinoma bearing rats.

Authors:  Sengodan Sundravel; Palanivel Shanthi; Panchanadham Sachdanandam
Journal:  Mol Cell Biochem       Date:  2006-05-12       Impact factor: 3.396

6.  Catechol-O-methyltransferase polymorphism and endometriosis.

Authors:  Fritz Wieser; Rene Wenzl; Clemens Tempfer; Christoph Worda; Johannes Huber; Christian Schneeberger
Journal:  J Assist Reprod Genet       Date:  2002-07       Impact factor: 3.412

7.  Unique tissue-specific level of DNA nucleotide excision repair in primary human mammary epithelial cultures.

Authors:  Jean J Latimer; Tariq Nazir; Lisa C Flowers; Michael J Forlenza; Kelly Beaudry-Rodgers; Crystal M Kelly; Julie A Conte; Kenneth Shestak; Amal Kanbour-Shakir; Stephen G Grant
Journal:  Exp Cell Res       Date:  2003-11-15       Impact factor: 3.905

8.  Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors.

Authors:  Page E Abrahamson; Shelley S Tworoger; Erin J Aiello; Leslie Bernstein; Cornelia M Ulrich; Frank D Gilliland; Frank Z Stanczyk; Richard Baumgartner; Kathy Baumgartner; Bess Sorensen; Rachel Ballard-Barbash; Anne McTiernan
Journal:  Breast Cancer Res Treat       Date:  2006-11-01       Impact factor: 4.872

9.  Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin.

Authors:  Sarah M Mense; Jaimeet Chhabra; Hari K Bhat
Journal:  J Steroid Biochem Mol Biol       Date:  2008-03-29       Impact factor: 4.292

10.  Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk.

Authors:  Marc T Goodman; Galina Lurie; Pamela J Thompson; Katharine E McDuffie; Michael E Carney
Journal:  Endocr Relat Cancer       Date:  2008-07-30       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.